Egg Freezing And Embryo Banking Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Donor, Non-donor), By Preservation (Egg freezing, Embryo Freezing), By Region, and Competition, 2020-2030F

Market Overview

The Global Egg Freezing And Embryo Banking Market, valued at USD 4.49 Billion in 2024, is projected to experience a CAGR of 16.56% to reach USD 11.26 Billion by 2030. The Global Egg Freezing and Embryo Banking Market encompasses advanced reproductive technologies for cryopreserving unfertilized oocytes and fertilized embryos, enabling individuals and couples to preserve their reproductive potential for future use. Market expansion is primarily propelled by societal shifts towards delayed parenthood, significant advancements in cryopreservation methodologies improving success rates, and increasing awareness of fertility preservation options. According to the Society for Assisted Reproductive Technology (SART), in 2023, just under 40,000 egg freezing cycles were completed, marking a substantial increase of over 39% from 2022 in the United States.

Additionally, the rising global incidence of infertility continues to fuel demand for these services. However, a considerable challenge impeding market growth involves the substantial financial burden associated with both initial procedural costs and ongoing storage fees, which can restrict broader access to these fertility preservation techniques.

Key Market Drivers

The growing trend of delayed parenthood significantly drives the global egg freezing and embryo banking market as individuals increasingly prioritize education, career advancement, and personal development before starting families. This societal shift leads to women postponing childbirth to an age when natural fertility may have declined, prompting them to seek fertility preservation options. For instance, according to Extend Fertility, in November 2024, Extend Fertility's 8-Year Research Study Is Great News For Egg Freezing Patients, the average age of patients choosing to freeze their eggs decreased from 37 years in 2016 to approximately 35 years by 2023, indicating a proactive approach to preserving fertility earlier in life. This desire for reproductive autonomy, combined with improved cryopreservation technologies, directly fuels the demand for egg freezing and embryo banking services, enabling individuals to align their reproductive timelines with their life goals.

Concurrently, increasing global infertility rates represent another critical catalyst for market expansion. A substantial portion of the adult population faces challenges in conceiving naturally, necessitating advanced reproductive technologies to achieve pregnancy. According to the World Health Organization, in April 2023, Infertility Prevalence Estimates, 1990–2021, approximately 17.5% of the adult population globally experienced infertility, highlighting the widespread need for fertility solutions. Egg freezing and embryo banking offer viable pathways to parenthood for those contending with various forms of infertility, whether due to age, medical conditions, or other factors. This fundamental demand for fertility treatment continues to propel the market forward, evidenced by the rising number of successful outcomes. According to the Society for Assisted Reproductive Technology, in 2023, the number of babies born from IVF in the United States increased to 95,860.

Download Free Sample Report

Key Market Challenges

A significant obstacle to the expansion of the Global Egg Freezing and Embryo Banking Market is the considerable financial burden placed on individuals. The high initial procedural costs, which can range from several thousand dollars for a single egg freezing cycle, combined with recurring annual storage fees for cryopreserved gametes and embryos, present a substantial barrier to entry for many prospective patients. These expenses often remain largely uncovered by standard health insurance policies, necessitating significant out-of-pocket payments.

The direct consequence of this financial barrier is restricted access and reduced utilization of these advanced reproductive technologies. For instance, according to a 2023 publication in ASCO Publications, 19% of pediatric and young adult oncology providers in the United States and Canada identified insurance issues and high costs as critical barriers to offering fertility preservation services to their patients. While specific to oncology patients, this highlights a broader market dynamic where financial constraints prevent a segment of the population from accessing vital fertility preservation. This economic reality limits the potential customer base, thereby directly hampering the overall growth trajectory of the Global Egg Freezing and Embryo Banking Market by excluding a considerable number of individuals and couples who could otherwise benefit from these services.

Key Market Trends

Two prominent trends are significantly shaping the global egg freezing and embryo banking market, distinct from the established drivers of delayed parenthood and rising infertility rates.

The **Integration of Artificial Intelligence in Embryo Selection** marks a substantial technological advancement, enhancing the precision and effectiveness of fertility treatments. AI systems analyze complex morphological data from embryos, providing objective assessments that complement human expertise. A study presented at the ASRM 2023 annual meeting, for example, indicated that an AI model achieved a clinical pregnancy rate of 62.1% compared to 61.0% for embryos selected by embryologists. This technological integration can lead to higher success rates for patients by identifying the most viable embryos. Ovation Fertility and Alife Health, in their interim analysis presented at the 80th ASRM Scientific Congress & Expo in October 2024, further demonstrated this impact, showing that an AI-assisted group achieved a 69% ongoing pregnancy rate, compared to 64% in a control group. This trend not only improves outcomes but also streamlines laboratory processes, potentially increasing access to services.

Concurrently, **Increasing Private Equity Investment in Fertility Services** is transforming the market landscape by driving consolidation, expanding infrastructure, and injecting capital for growth and innovation. This influx of investment reflects strong market confidence in the long-term potential of fertility preservation and treatment. According to the Society for Assisted Reproductive Technology (SART), the total number of IVF cycles performed at its member clinics increased by approximately 11% from 389,993 in 2022 to 432,641 in 2023, indicating a market responsive to increased capital and operational efficiencies. Private equity firms invested approximately $2.9 billion across 30 global fertility sector buyouts in 2023, as reported in an August 2025 publication in PubMed Central. This financial trend facilitates the expansion of fertility clinic networks and specialized cryobanks, making advanced reproductive technologies more accessible to a broader patient base.

Segmental Insights

The Non-Donor segment is experiencing rapid growth in the Global Egg Freezing And Embryo Banking Market, driven primarily by evolving societal trends and individual preferences for genetic parenthood. A significant factor is the increasing number of individuals electing to delay childbearing due to career aspirations, personal development, or other life circumstances. This demographic shift fosters a strong preference among women to preserve their own eggs for future use, ensuring genetic linkage to their offspring. Furthermore, advancements in cryopreservation techniques, such as vitrification, have significantly improved the viability and success rates of freezing and thawing a woman's own eggs and embryos, thereby enhancing confidence in these fertility preservation methods. Coupled with rising awareness regarding fertility decline with age and medical necessities, the Non-Donor segment is poised for continued expansion.

Regional Insights

Europe leads the global egg freezing and embryo banking market due to its advanced healthcare infrastructure and well-established presence in assisted reproductive technology. Regional governments consistently invest in technological adoption, enhancing the availability of sophisticated reproductive options. Furthermore, certain European countries feature progressive regulatory frameworks, such as those in Spain, which are notably inclusive regarding access for single women and same-sex couples, and permit fertility preservation for social reasons. This conducive environment, coupled with increasing demand driven by evolving lifestyle choices and a growing awareness of fertility preservation, attracts substantial medical tourism. Patients from other regions frequently travel to Europe, seeking high-quality care within these supportive legal and technological landscapes.

Recent Developments

• In January 2025, NewGenIvf Group Limited introduced an innovative lifetime egg freezing service across Asia. This new offering allows individuals to make a single payment for indefinite egg storage, eliminating concerns about recurring fees or time limits for fertility preservation. The service directly addresses a growing market demand for reproductive flexibility among women, particularly working professionals. NewGenIvf aims to establish brand awareness and cultivate partnerships with key healthcare providers to support this initiative within the global egg freezing and embryo banking market.

• In October 2024, Extend Fertility announced the findings of its extensive 8-year study, which showcased exceptional success rates for egg freezing. The research highlighted that over 90% of thawed eggs survived the process, and an impressive pregnancy success rate of more than 55% was observed, including live births and pregnancies past 12 weeks. These results affirm the significant potential of egg freezing for women seeking to manage their reproductive futures, contributing valuable data to the global egg freezing and embryo banking market.

• In July 2024, the London Women's Clinic released the outcomes of Britain's most comprehensive study on egg freezing, published in a peer-reviewed journal. The research analyzed nearly 30,000 frozen eggs, reporting live birth rates per embryo transfer that were comparable to those achieved through routine in-vitro fertilization (IVF). This study further established consistent and predictable success patterns in egg freezing, with results indicating that female age at the time of freezing is a significant variable in the cumulative live birth rate.

• In March 2024, TMRW Life Sciences launched CryoLink, a specialized workstation intended for the digital management of frozen specimen inventories in fertility clinics. This product was introduced as a platform aimed at enhancing standards within IVF laboratories. CryoLink is designed to improve the safety, accuracy, and efficiency of managing frozen eggs and embryos, thereby supporting the operational advancements of facilities participating in the global egg freezing and embryo banking market.

Key Market Players

• ReproTech LLC
• Cryo-Cell International Inc
• CCRM Fertility Clinic and IVF Clinic
• RMA Fertility Clinics
• Carrot Fertility Inc
• WINFertility, Inc.
• Shady Grove Fertility Reproductive Science Center
• Kindbody

Report Scope:

In this report, the Global Egg Freezing And Embryo Banking Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Egg Freezing And Embryo Banking Market, By Type:

o   Donor

o   Non-donor

• Egg Freezing And Embryo Banking Market, By Preservation:

o   Egg freezing

o   Embryo Freezing

• Egg Freezing And Embryo Banking Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Egg Freezing And Embryo Banking Market.

Available Customizations:

Global Egg Freezing And Embryo Banking Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Egg Freezing And Embryo Banking Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]